Markers of insulin resistance in Polycystic ovary syndrome women: An update

被引:40
|
作者
Amisi, Chantal Anifa [1 ]
机构
[1] Univ Campus Biomed Rome, Endocrinol & Diabet Unit, Dept Med, Via Alvaro del Portillo 21, I-00128 Rome, Italy
关键词
Markers; Insulin resistance; Polycystic ovary syndrome; Emerging markers; Impaired glucose tolerance; HOMEOSTASIS MODEL ASSESSMENT; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; GLUCOSE-TOLERANCE TEST; BODY-FAT DISTRIBUTION; BETA-CELL FUNCTION; SERUM-LIPOPROTEIN RATIOS; NECROSIS-FACTOR-ALPHA; TO-HEIGHT RATIO;
D O I
10.4239/wjd.v13.i3.129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5%-10% of women of reproductive age. The importance of this syndrome lies in the magnitude of associated comorbidities: infertility, metabolic dysfunction, cardiovascular disease (CVD), plus psychological and oncological complications. Insulin resistance (IR) is a prominent feature of PCOS with a prevalence of 35%-80%. Without adequate management, IR with compensatory hyperinsulinemia contributes directly to reproductive dysfunction in women with PCOS. Furthermore, epidemiological data shows compelling evidence that PCOS is associated with an increased risk of impaired glucose tolerance, gestational diabetes mellitus and type 2 diabetes. In addition, metabolic dysfunction leads to a risk for CVD that increases with aging in women with PCOS. Indeed, the severity of IR in women with PCOS is associated with the amount of abdominal obesity, even in lean women with PCOS. Given these drastic implications, it is important to diagnose and treat insulin resistance as early as possible. Many markers have been proposed. However, quantitative assessment of IR in clinical practice remains a major challenge. The gold standard method for assessing insulin sensitivity is the hyperinsulinemic euglycemic glucose clamp. However, it is not used routinely because of the complexity of its procedure. Consequently, there has been an urgent need for surrogate markers of IR that are more applicable in large population-based epidemiological investigations. Despite this, many of them are either difficult to apply in routine clinical practice or useless for women with PCOS. Considering this difficulty, there is still a need for an accurate marker for easy, early detection and assessment of IR in women with PCOS. This review highlights markers of IR already used in women with PCOS, including new markers recently reported in literature, and it establishes a new classification for these markers.
引用
收藏
页码:129 / 149
页数:21
相关论文
共 50 条
  • [31] Insulin resistance and polycystic ovary syndrome
    Galluzzo, Aldo
    Amato, Marco Calogero
    Giordano, Carla
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (07) : 511 - 518
  • [32] Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome
    Kowalska, Irina
    Straczkowski, Marek
    Nikolajuk, Agnieszka
    Adamska, Agnieszka
    Karczewska-Kupczewska, Monika
    Otziomek, Elzbieta
    Wolczynski, Slawomir
    Gorska, Maria
    [J]. HUMAN REPRODUCTION, 2007, 22 (07) : 1824 - 1829
  • [33] The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers
    Xita, Nectaria
    Papassotiriou, Ioannis
    Georgiou, Ioannis
    Vounatsou, Maria
    Margeli, Alexandra
    Tsatsoulis, Agathocles
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (06): : 766 - 771
  • [34] Plasma homocysteine and insulin resistance in women with polycystic ovary syndrome.
    Ardawi, MS
    Rouzi, AA
    [J]. FERTILITY AND STERILITY, 2005, 84 : S432 - S432
  • [35] Adrenomedullin: Possible predictor of insulin resistance in women with polycystic ovary syndrome
    Sahin, I.
    Celik, O.
    Celik, N.
    Keskin, L.
    Dogru, A.
    Dogru, I.
    Yurekli, M.
    Yologlu, S.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (06) : 553 - 556
  • [36] Adrenomedullin: Possible predictor of insulin resistance in women with polycystic ovary syndrome
    I. Şahin
    Ö. Çelik
    N. Çelik
    L. Keskin
    A. Doğru
    I. Doğru
    M. Yürekli
    S. Yoloğlu
    [J]. Journal of Endocrinological Investigation, 2012, 35 : 553 - 556
  • [37] Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi, MS
    Rouzi, AA
    [J]. FERTILITY AND STERILITY, 2004, 82 : S307 - S308
  • [38] Insulin resistance and arterial stiffness in young women with polycystic ovary syndrome
    Dagre, A.
    Alevizaki, M.
    Papaioannou, T. G.
    Tryfonopoulos, D. J.
    Douridas, G. N.
    Papamichael, C. M.
    Protogerou, A. D.
    Lekakis, J. P.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 692 - 692
  • [39] Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome
    Kilic-Okman, T
    Guldiken, S
    Kucuk, M
    [J]. ENDOCRINE JOURNAL, 2004, 51 (05) : 505 - 508
  • [40] Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome
    Gulcelik, Nese Ersoz
    Aral, Yalcin
    Serter, Rustu
    Demir, Yavuz
    Culha, Cavit
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (09) : 511 - 515